Previous studies reported that both ApoM- and HDL-associated d18:1-S1P were decreased in patients with T2D [31–33], however none evaluated the association between circulating concentrations of S1P species and their precursors and the risk of cardiovascular diseases in patients with T2D. This evidence concerns the gene APOM and type 2 diabetes mellitus.